Abstracts tagged "Best practices"

Abstract Number: 337 • 2018 ACR/ARHP Annual Meeting
Does a Best Practice Alert Improve RA Patient Referral to Preventative Cardiology?
Savanna Smoker¹, Ellen Romich², Amy Nowacki³ and M. Elaine Husni⁴, ¹Case Western Reserve University, Cleveland, OH, ²Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, ³Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁴Rheumatology, Cleveland Clinic, Cleveland, OH
Background/Purpose: RA patients are at about 50% increased risk of cardiovascular disease (CVD)1. Despite this risk, numerous studies show inadequate cardiovascular risk assessment of these…
Abstract Number: 2859 • 2018 ACR/ARHP Annual Meeting
Do Preventive Cardiology Consults Versus Usual Care Improve Cardiovascular Risk Factor Assessment and Management in Patients with Rheumatoid Arthritis?
Ellen Romich¹, Haitham Ahmed², Amy Nowacki³ and M. Elaine Husni⁴, ¹Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, ²Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, ³Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁴Rheumatology, Cleveland Clinic, Cleveland, OH
Background/Purpose: Rheumatoid arthritis (RA) patients have around 50% increased risk of cardiovascular disease (CVD). Both traditional and RA-specific cardiovascular (CV) risk factors contribute to the…
Abstract Number: 1040 • 2017 ACR/ARHP Annual Meeting
Perceptions of US Community Rheumatologists on Biosimilars
Janna Radtchenko, Yolaine Smith, Jonathan Kish and Bruce Feinberg, Specialty Solutions, Cardinal Health, Dallas, TX
Background/Purpose: Biosimilars contain a highly similar version of the active substance of an already approved biologic or “reference product.”1 Regulatory agencies mandate that safety, efficacy,…
Abstract Number: 472 • 2015 ACR/ARHP Annual Meeting
Quality Assessment in Clinical Management of Patients with Rheumatoid Arthritis. Are We Using the “Treat to Target” Strategy?
Jose Luis Andreu^1,2, Maria Auxiliadora Martin³, H Corominas⁴, Jose Javier Perez Venegas⁵, Jose Andres Roman Ivorra^6,7, Angel Gil⁸, Fernando Sánchez-Alonso⁹, Tamara Jiménez¹⁰ and Miguel Angel Sánchez-Ruiz¹⁰, ¹Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain, ²Rheumatology, HU Puerta de Hierro Majadahonda, Madrid, Spain, ³Research Unit of Spanish Society of Rheumatology,, Madrid, Spain, ⁴CapiCAT group (Nailfold Capillaroscopy group from the Catalan Society for Rheumatology)., Catalonia, Spain, ⁵Rheumatology, Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain, ⁶Rheumatology, H.U. P. La Fe, Valencia, Spain, ⁷Servicio de Reumatología, Servicio de Reumatología Hospital Universitario La Fe, Valencia, Spain, ⁸Cátedra de Resultados en Salud, Universidad Rey Juan Carlos, Madrid, Spain, ⁹Unidad de Investigación. Sociedad Española de Reumatología, Madrid, Spain, ¹⁰Universidad Rey Juan Carlos, Madrid, Spain
Background/Purpose: The current paradigm of optimal clinical management of patients with rheumatoid arthritis (RA) recommends reaching a state of remission or low activity of the disease,…
Abstract Number: 2485 • 2015 ACR/ARHP Annual Meeting
Quality of Evidence of the American College of Rheumatology (ACR) Clinical Practice Guidlines
Mushabab Alghamdi¹ and Mohammed Al Mansour², ¹Internal Medicine, University of Bisha, Bisha, Saudi Arabia, ²Rheumatology, King Fahad Medical City, Riyadh, Saudi Arabia
Background/Purpose: The American College of Rheumatology (ACR) regularly establishes and publishes guidelines for the management of various rheumatic diseases. These guidelines assist physicians in providing…
Abstract Number: 2313 • 2014 ACR/ARHP Annual Meeting
Best Practices for Best Practice Alerts: Evaluation of a Best Practice Alert to Detect Chronic Glucocorticoid Use
Mingyuan Zhang¹, Catherine Staes¹, Lara Kapp² and Karla L. Miller³, ¹Department of Biomedical Informatics, University of Utah, Salt Lake City, UT, ²University of Utah School of Medicine, Salt Lake City, UT, ³Internal Medicine-Division of Rheumatology, University of Utah School of Medicine, SLC, UT
Background/Purpose Chronic glucocorticoid (GC) use is a known risk factor for osteoporosis and fracture. Patients with chronic GC use often receive suboptimal osteoporosis prevention, diagnosis,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].